GLUE Financial Statements

Balance sheet, income statement, cash flow, and dividends for Monte Rosa Therapeutics Inc (GLUE).


$426.37M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

GLUE Market Cap. (MRY)


GLUE Shares Outstanding (MRY)


GLUE Assets (MRY)


Total Assets

$438.73M

Total Liabilities

$215.80M

Total Investments

$147.90M

GLUE Income (MRY)


Revenue

$75.62M

Net Income

-$72.70M

Operating Expense

$156.73M

GLUE Cash Flow (MRY)


CF Operations

$42.00M

CF Investing

-$44.45M

CF Financing

$98.89M

GLUE Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

GLUE Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$438,732,000 (44.44%)

$303,755,000 (-11.28%)

$342,389,000 (-6.54%)

$366,329,000 (641.89%)

Assets Current

$377,440,000 (59.79%)

$236,212,000 (-14.38%)

$275,886,000 (-20.87%)

$348,666,000 (699.86%)

Assets Non-Current

$61,292,000 (-9.25%)

$67,543,000 (1.56%)

$66,503,000 (276.51%)

$17,663,000 (205.22%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$222,936,000 (24.37%)

$179,250,000 (-33.96%)

$271,413,000 (-21.90%)

$347,515,000 (813.17%)

Property Plant & Equipment Net

$56,314,000 (-10.06%)

$62,611,000 (1.14%)

$61,907,000 (402.29%)

$12,325,000 (166.60%)

Cash & Equivalents

$229,117,000 (78.86%)

$128,101,000 (129.28%)

$55,872,000 (-83.86%)

$346,071,000 (707.39%)

Accumulated Other Comprehensive Income

-$3,356,000 (-23.20%)

-$2,724,000 (-55.48%)

-$1,752,000 (13.31%)

-$2,021,000 (-91.38%)

Deferred Revenue

$133,379,000 (166.75%)

$50,001,000 (0%)

$0 (0%)

$0 (0%)

Total Investments

$147,895,000 (35.82%)

$108,892,000 (-48.69%)

$212,232,000 (3875.87%)

$5,338,000 (0%)

Investments Current

$147,895,000 (41.78%)

$104,312,000 (-49.83%)

$207,914,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$4,580,000 (6.07%)

$4,318,000 (-19.11%)

$5,338,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$173,000 (-65.74%)

$505,000 (-93.40%)

$7,656,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$17,215,000 (54.37%)

$11,152,000 (41.85%)

$7,862,000 (19.88%)

$6,558,000 (-7.19%)

Accumulated Retained Earnings (Deficit)

-$438,588,000 (-19.87%)

-$365,888,000 (-58.71%)

-$230,536,000 (-88.91%)

-$122,035,000 (-153.83%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$42,715,000 (-7.22%)

$46,039,000 (-2.05%)

$47,001,000 (0%)

$0 (0%)

Debt Current

$3,714,000 (17.46%)

$3,162,000 (1.12%)

$3,127,000 (0%)

$0 (0%)

Debt Non-Current

$39,001,000 (-9.04%)

$42,877,000 (-2.27%)

$43,874,000 (0%)

$0 (0%)

Total Liabilities

$215,796,000 (73.32%)

$124,505,000 (75.42%)

$70,976,000 (277.25%)

$18,814,000 (-37.99%)

Liabilities Current

$156,946,000 (236.85%)

$46,592,000 (82.22%)

$25,569,000 (53.68%)

$16,638,000 (-43.17%)

Liabilities Non-Current

$58,850,000 (-24.47%)

$77,913,000 (71.59%)

$45,407,000 (1986.72%)

$2,176,000 (103.94%)

GLUE Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$75,622,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$35,171,000 (9.78%)

$32,039,000 (17.26%)

$27,323,000 (73.73%)

$15,727,000 (292.68%)

Research & Development Expense

$121,563,000 (9.25%)

$111,272,000 (30.81%)

$85,061,000 (48.83%)

$57,155,000 (138.10%)

Operating Expenses

$156,734,000 (9.37%)

$143,311,000 (27.52%)

$112,384,000 (54.20%)

$72,882,000 (160.20%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$2,570,000 (660.36%)

$338,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$72,700,000 (46.29%)

-$135,352,000 (-24.75%)

-$108,501,000 (-46.71%)

-$73,958,000 (-106.13%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$72,700,000 (46.29%)

-$135,352,000 (-24.75%)

-$108,501,000 (-46.71%)

-$73,958,000 (-106.13%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$72,700,000 (46.29%)

-$135,352,000 (-24.75%)

-$108,501,000 (-46.71%)

-$73,958,000 (-106.13%)

Weighted Average Shares

$73,910,026 (43.80%)

$51,396,961 (8.83%)

$47,227,370 (88.91%)

$25,000,124 (1548.09%)

Weighted Average Shares Diluted

$73,910,026 (43.80%)

$51,396,961 (8.83%)

$47,227,370 (88.91%)

$25,000,124 (1548.09%)

Earning Before Interest & Taxes (EBIT)

-$70,130,000 (48.06%)

-$135,014,000 (-24.44%)

-$108,501,000 (-46.71%)

-$73,958,000 (-106.13%)

Gross Profit

$75,622,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$81,112,000 (43.40%)

-$143,311,000 (-27.52%)

-$112,384,000 (-54.20%)

-$72,882,000 (-160.20%)

GLUE Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$44,452,000 (-150.06%)

$88,801,000 (140.51%)

-$219,219,000 (-2170.99%)

-$9,653,000 (-184.83%)

Net Cash Flow from Financing

$98,892,000 (259.71%)

$27,492,000 (34.33%)

$20,466,000 (-94.58%)

$377,562,000 (528.64%)

Net Cash Flow from Operations

$41,996,000 (195.88%)

-$43,802,000 (52.63%)

-$92,466,000 (-55.76%)

-$59,363,000 (-157.51%)

Net Cash Flow / Change in Cash & Cash Equivalents

$96,436,000 (33.03%)

$72,491,000 (124.89%)

-$291,219,000 (-194.38%)

$308,546,000 (817.80%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$40,464,000 (-137.54%)

$107,780,000 (152.21%)

-$206,417,000 (0%)

$0 (0%)

Capital Expenditure

-$3,988,000 (78.99%)

-$18,979,000 (-48.25%)

-$12,802,000 (-32.62%)

-$9,653,000 (-184.83%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$98,892,000 (3691.87%)

$2,608,000 (-87.26%)

$20,466,000 (-91.40%)

$237,899,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$18,126,000 (8.74%)

$16,669,000 (42.91%)

$11,664,000 (124.31%)

$5,200,000 (1368.93%)

Depreciation Amortization & Accretion

$8,121,000 (30.52%)

$6,222,000 (-27.30%)

$8,559,000 (301.45%)

$2,132,000 (297.02%)

GLUE Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

-

Profit Margin

-96.10%

-

-

-

EBITDA Margin

-82.00%

-

-

-

Return on Average Equity (ROAE)

-36.10% (45.22%)

-65.90% (-80.55%)

-36.50% (-25.00%)

-29.20% (-124.77%)

Return on Average Assets (ROAA)

-21.30% (54.97%)

-47.30% (-53.57%)

-30.80% (-35.09%)

-22.80% (80.79%)

Return on Sales (ROS)

-92.70%

-

-

-

Return on Invested Capital (ROIC)

-41.20% (28.84%)

-57.90% (-41.91%)

-40.80% (98.97%)

-3978.40% (-1455.50%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-7.08 (-229.70%)

-2.15 (35.09%)

-3.31 (52.04%)

-6.9

Price to Sales Ratio (P/S)

6.78

-

-

-

Price to Book Ratio (P/B)

1.91 (21.15%)

1.58 (16.36%)

1.36 (-50.35%)

2.73

Debt to Equity Ratio (D/E)

0.97 (39.28%)

0.69 (165.27%)

0.26 (385.19%)

0.05 (108.67%)

Earnings Per Share (EPS)

-0.98 (62.74%)

-2.63 (-14.35%)

-2.3 (22.30%)

-2.96 (87.48%)

Sales Per Share (SPS)

1.02 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

0.51 (142.10%)

-1.22 (45.22%)

-2.23 (19.27%)

-2.76 (84.16%)

Book Value Per Share (BVPS)

3.02 (-13.53%)

3.49 (-39.31%)

5.75 (-58.66%)

13.9 (143.27%)

Tangible Assets Book Value Per Share (TABVPS)

5.94 (0.44%)

5.91 (-18.48%)

7.25 (-50.52%)

14.65 (-54.99%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-150.00%)

-2 (33.33%)

-3 (62.50%)

-8

Enterprise Value Over EBITDA (EV/EBITDA)

-5.48 (-160.89%)

-2.1 (30.22%)

-3.01 (62.80%)

-8.09

Asset Turnover

0.22 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.4 (-52.56%)

5.07 (-53.01%)

10.79 (-48.51%)

20.96 (1307.39%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$38,008,000 (160.54%)

-$62,781,000 (40.36%)

-$105,268,000 (-52.53%)

-$69,016,000 (-161.01%)

Enterprise Value (EV)

$339,585,976 (25.63%)

$270,300,780 (-10.09%)

$300,620,816 (-48.25%)

$580,887,764

Earnings Before Tax (EBT)

-$70,130,000 (48.06%)

-$135,014,000 (-24.44%)

-$108,501,000 (-46.71%)

-$73,958,000 (-106.13%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$62,009,000 (51.85%)

-$128,792,000 (-28.87%)

-$99,942,000 (-39.14%)

-$71,826,000 (-103.23%)

Invested Capital

$95,384,000 (-45.53%)

$175,101,000 (-43.14%)

$307,949,000 (8406.88%)

$3,620,000 (115.91%)

Working Capital

$220,494,000 (16.28%)

$189,620,000 (-24.25%)

$250,317,000 (-24.61%)

$332,028,000 (2219.28%)

Tangible Asset Value

$438,732,000 (44.44%)

$303,755,000 (-11.28%)

$342,389,000 (-6.54%)

$366,329,000 (641.89%)

Market Capitalization

$426,370,976 (50.68%)

$282,957,780 (-23.18%)

$368,316,816 (-61.22%)

$949,650,764

Average Equity

$201,395,750 (-1.90%)

$205,288,500 (-31.02%)

$297,607,500 (17.53%)

$253,220,500 (931.92%)

Average Assets

$341,168,000 (19.34%)

$285,875,500 (-18.96%)

$352,763,250 (8.55%)

$324,980,500 (974.81%)

Invested Capital Average

$170,116,750 (-27.09%)

$233,336,000 (-12.20%)

$265,745,000 (14195.05%)

$1,859,000 (115.20%)

Shares

61,436,740 (22.67%)

50,081,023 (3.48%)

48,399,056 (4.07%)

46,505,914 (9.32%)